Tag #Experimental Treatment

Showing 1 to 4 of 4 results

dailymail.co.uk

🌐 85% Global Worthiness

May 9, 10:14

Top Cancer Researcher Awaits Critical MRI Results Amidst Stage Four Brain Cancer Return

Professor Richard Scolyer, a leading cancer researcher and 2024 Australian of the Year, awaits crucial MRI results following the return of his stage four brain cancer, highlighting the unpredictable nature of glioblastoma and the need for improved treatments.

Top Cancer Researcher Awaits Critical MRI Results Amidst Stage Four Brain Cancer Return

Professor Richard Scolyer, a leading cancer researcher and 2024 Australian of the Year, awaits crucial MRI results following the return of his stage four brain cancer, highlighting the unpredictable nature of glioblastoma and the need for improved treatments.

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate implications of Professor Scolyer's upcoming MRI results for his treatment plan and life expectancy?

Professor Richard Scolyer, the 2024 Australian of the Year, faces a grim prognosis after his stage four brain cancer returned. Despite experimental treatments extending his life for nearly two years, recent scans reveal a concerning progression. He awaits MRI results to determine his next course of treatment, acknowledging the uncertainty of his remaining time.

smh.com.au

🌐 85% Global Worthiness

Mar 10, 10:11

Brain Tumor Regrowth Leaves Former Australian of the Year with Months to Live

Former Australian of the Year Professor Richard Scolyer's aggressive brain tumor has regrown after multiple surgeries and experimental treatment, leaving him with a prognosis of months to live, despite exceeding typical survival rates by nine months; his case informs a world-first clinical trial for...

Brain Tumor Regrowth Leaves Former Australian of the Year with Months to Live

Former Australian of the Year Professor Richard Scolyer's aggressive brain tumor has regrown after multiple surgeries and experimental treatment, leaving him with a prognosis of months to live, despite exceeding typical survival rates by nine months; his case informs a world-first clinical trial for...

Progress

20% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of Professor Scolyer's diagnosis on his life expectancy and treatment plan?

Professor Richard Scolyer, former Australian of the Year, has learned his aggressive brain tumor has regrown after surgery, leaving him with months to live. Despite undergoing experimental treatment and multiple surgeries, the tumor infiltrated vital brain areas, limiting removal options. He is now focusing on palliative care while appreciating the 21 months he's exceeded typical survival rates for this type of glioblastoma.

abcnews.go.com

🌐 85% Global Worthiness

Mar 20, 04:13

Early Amyloid Removal Halves Alzheimer's Risk in Genetic Study

A new study shows that an experimental treatment using amyloid-removing drugs has halved the risk of Alzheimer's symptom onset in a subset of 22 participants with a genetic predisposition to the disease, treated for an average of eight years, raising concerns about funding cuts that could halt the r...

Early Amyloid Removal Halves Alzheimer's Risk in Genetic Study

A new study shows that an experimental treatment using amyloid-removing drugs has halved the risk of Alzheimer's symptom onset in a subset of 22 participants with a genetic predisposition to the disease, treated for an average of eight years, raising concerns about funding cuts that could halt the r...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does this research advance our understanding of the amyloid hypothesis and its role in Alzheimer's disease progression?

This research connects the long-held amyloid hypothesis with tangible clinical outcomes. By removing amyloid plaques years before symptom onset, the study demonstrates a potential pathway for delaying or even preventing Alzheimer's. The success hinges on early, long-term intervention, highlighting the importance of genetic screening and proactive treatment for those at high risk.

dw.com

🌐 75% Global Worthiness

Feb 5, 16:14

Spinal Cord Implant Shows Promise for ALS Treatment

A spinal cord implant significantly improved muscle strength and mobility in three ALS patients, showing promise for a new treatment approach to this incurable genetic disease, according to a small, one-month pilot study published in Nature Medicine.

Spinal Cord Implant Shows Promise for ALS Treatment

A spinal cord implant significantly improved muscle strength and mobility in three ALS patients, showing promise for a new treatment approach to this incurable genetic disease, according to a small, one-month pilot study published in Nature Medicine.

Progress

20% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate impacts of spinal cord stimulation on ALS patients' motor function, based on this study?

A spinal cord implant improved muscle strength and mobility in three adults with amyotrophic lateral sclerosis (ALS), a debilitating genetic disease. The implant delivered controlled electrical impulses, resulting in increased walking distance and the ability to stand from a kneeling position for one participant who was previously unable to do so. This is the first evidence suggesting that spinal stimulation could also help with neurodegenerative diseases.

Showing 1 to 4 of 4 results